Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel biaryl ligand synthesis via Catellani reaction offers high enantioselectivity and scalable routes for pharmaceutical intermediates.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline. Metal-free, green chemistry, cost-effective for pharma intermediates. Reliable supply chain partner.
Patent CN115353482B reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN115925527B details a Ru-catalyzed method for high-purity API intermediate synthesis, offering significant cost reduction and supply chain reliability for global buyers.
Patent CN113307778A details a novel Mo-Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering mild conditions and high efficiency for reliable pharmaceutical intermediate suppliers.
Patent CN113121462A reveals a metal-free route for 5-trifluoromethyl-1,2,3-triazoles. This method offers cost reduction in pharmaceutical intermediate manufacturing via mild conditions.
Patent CN116640146B reveals efficient Pd-catalyzed route for trifluoromethyl chromone quinoline intermediates offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Novel scalable route for tegoprazan key intermediate offering high purity ≥99% and simplified post-processing for reliable pharmaceutical supply chains.
Novel iodine-promoted method for 3,4,5-trisubstituted 1,2,4-triazoles offers cost-effective, scalable routes for API manufacturing without heavy metals.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN115286553B reveals nickel-catalyzed carbonylation for indole synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 quinazolinones. Enhances purity and reduces toxic gas usage for API manufacturing.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering high yields and broad substrate tolerance for API intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Offers cost-effective, scalable routes for API intermediates without heavy metals.
Patent CN111592507A reveals a metal-free route to polysubstituted furans using BF3 catalysis, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106938984B reveals a novel one-pot method for 5-substituted quinolines. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN115197124B reveals mild ammonium iodide catalysis for pyridine derivatives. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN110590621B details a mild copper-catalyzed route for 1,2-bis(arylsulfonyl) ethylene derivatives, offering cost reduction and scalable manufacturing for fine chemical intermediates.
Patent CN111410656B details a novel copper-catalyzed route to isoquinolinones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production capabilities.
Novel palladium-catalyzed route for 3-alkynylbenzofuran compounds ensures high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.